You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通策醫療(600763.SH):上半年淨利降30.22%至1.45億元
格隆匯 08-03 18:36

格隆匯 8 月 3日丨通策醫療(600763.SH)披露2020年半年度報告,實現營業收入7.38億元,同比下降12.87%;歸屬於上市公司股東的淨利潤1.45億元,同比下降30.22%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.37億元,同比下降32.86%;基本每股收益0.45元。

2020年報告期內,面對新冠肺炎疫情帶來的嚴峻考驗和複雜多變的國內外環境,公司在呂建明董事長的帶領下,在希望與忙碌中走過了上半年。公司上下統籌推進疫情防控和業務發展各項工作,堅決貫徹落實各項戰略行動計劃,各項工作加快推進。上半年,公司業務先降後升,二季度主要財務指標恢復性增長。公司口腔醫療服務營業面積達到16萬平米,開設牙椅1753台,口腔醫療門診量82.48萬人次,公司報告期內實現總營業收入7.38億元,比去年同期下降12.87%;主要原因是受一季度營業收入同比下降影響所致,二季度營業收入同比增長20.39%,已恢復正常增長態勢。公司實現歸屬於上市公司股東的淨利潤1.45億元,同比下降30.22%,主要原因是受一季度因疫情影響導致歸屬於上市公司股東的淨利潤下滑拖累,二季度實現歸屬於上市公司股東的淨利潤同比增長44.63%,超過2019年度增長水平。公司實現基本每股收益0.45元/股,同比下降30.77%,其中二季度實現每股收益0.51元,較去年同期增長45.71%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account